Francoise Dixon - Mach7 Technologies Head Relations
M7T Stock | 0.34 0.02 5.56% |
Executive
Francoise Dixon is Head Relations of Mach7 Technologies
Address | 120 Kimball Avenue, South Burlington, VT, United States, 05403 |
Phone | 802 861 7745 |
Web | https://www.mach7t.com |
Mach7 Technologies Management Efficiency
The company has return on total asset (ROA) of (0.0837) % which means that it has lost $0.0837 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1432) %, meaning that it generated substantial loss on money invested by shareholders. Mach7 Technologies' management efficiency ratios could be used to measure how well Mach7 Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Liabilities And Stockholders Equity is likely to gain to about 76.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 1.9 M in 2024.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Forough Khandan | EMvision Medical Devices | N/A | |
Racheal Kellaway | Bank of Queensland | N/A | |
Dean Surkitt | Bell Financial Group | N/A | |
Lorna Stewart | Insignia Financial | N/A | |
Frank Lombardo | Insignia Financial | N/A | |
Joe Tillig | Bell Financial Group | N/A | |
Geoff Louw | Bell Financial Group | N/A | |
Greg Boyle | Bank of Queensland | N/A | |
Lawrence Hastings | Insignia Financial | N/A | |
Chris Kurinksy | Qbe Insurance Group | N/A | |
Craig Saunders | Bell Financial Group | N/A | |
Jason Sommer | Insignia Financial | N/A | |
BSc FCPA | Qbe Insurance Group | N/A | |
Arnie Selvarajah | Bell Financial Group | N/A | |
Geoff Kellett | Insignia Financial | N/A | |
Robert Tiller | EMvision Medical Devices | N/A | |
Gideon Lipman | Insignia Financial | N/A | |
James Unger | Bell Financial Group | N/A | |
Alastair Provan | Bell Financial Group | N/A | |
BCom CFA | Insignia Financial | N/A | |
Paul Byrne | Qbe Insurance Group | N/A |
Management Performance
Return On Equity | -0.14 | ||||
Return On Asset | -0.0837 |
Mach7 Technologies Leadership Team
Elected by the shareholders, the Mach7 Technologies' board of directors comprises two types of representatives: Mach7 Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mach7. The board's role is to monitor Mach7 Technologies' management team and ensure that shareholders' interests are well served. Mach7 Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mach7 Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Kelly Kimball, Vice Culture | ||
Bob Tranchida, Vice Marketing | ||
Michael Lampron, MD CEO | ||
Francoise Dixon, Head Relations | ||
Rebecca Thompson, Head Relations | ||
ACIS ACIS, Company Secretary | ||
Steven Parkes, Global Officer | ||
Dyan OHerne, Chief Officer | ||
David Madaffri, Chief Officer | ||
ACIS AGIA, Company Secretary | ||
Veronique MorganSmith, Company Sec |
Mach7 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mach7 Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.14 | ||||
Return On Asset | -0.0837 | ||||
Profit Margin | (0.27) % | ||||
Operating Margin | (0.29) % | ||||
Current Valuation | 57.11 M | ||||
Shares Outstanding | 241.24 M | ||||
Shares Owned By Insiders | 27.00 % | ||||
Shares Owned By Institutions | 23.94 % | ||||
Price To Book | 1.58 X | ||||
Price To Sales | 2.73 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mach7 Stock Analysis
When running Mach7 Technologies' price analysis, check to measure Mach7 Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mach7 Technologies is operating at the current time. Most of Mach7 Technologies' value examination focuses on studying past and present price action to predict the probability of Mach7 Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mach7 Technologies' price. Additionally, you may evaluate how the addition of Mach7 Technologies to your portfolios can decrease your overall portfolio volatility.